About
Listed competitors
Also in this space
Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Shares Biotech, HealthTech
Develops a computational model of the human body for drug discovery and development.
Shares Drug Discovery, Biotech
AI-powered platform for designing novel molecular structures for new medicines.
Shares Biotech, Drug Discovery
Data-driven drug discovery and development company using machine learning and high-throughput biology.
Shares Drug Discovery, Biotech
AI-powered biotechnology company developing RNA therapeutics for genetic diseases.
Shares Biotech, Drug Discovery
AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
Shares Biotech, Drug Discovery
Key facts
- Website
- aiomics.com
- Headquarters
- San Francisco, United States
- Total funding
- $2M (Pre-Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 17 Jan 2024 | Pre-Seed | $2M | High-Tech Gründerfonds, Bayern Kapital |
Aiomics scores 21. Does yours?
That is its Agent Readiness: how well ChatGPT, Claude and the other agents can read and use a site. Paste your website and you get yours in about a minute.
Frequently asked
Is Aiomics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Aiomics is 53 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Aiomics raised?
Aiomics has raised a total of $2M in funding. The most recent round on record is Pre-Seed.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Aiomics
